January 2019 Briefing - Pain Management

Share this content:

Here are what the editors at HealthDay consider to be the most important developments in Pain Management for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Patient Attitude Tied to Physical Therapy Outcomes

WEDNESDAY, Jan. 30, 2019 (HealthDay News) -- Patient expectation and pain self-efficacy are associated with clinical outcomes among patients undergoing physical therapy for shoulder pain, according to a study published online Jan. 24 in the British Journal of Sports Medicine.

Abstract/Full Text (subscription or payment may be required)

Evidence Lacking for Benefit of Surgery for Vertebral Fractures

MONDAY, Jan. 28, 2019 (HealthDay News) -- Surgical procedures do not appear to provide significant benefit for patients with vertebral fractures (VF), according to a second American Society for Bone and Mineral Research Task Force report published in the January issue of the Journal of Bone and Mineral Research.

Abstract/Full Text
Editorial

Report IDs Areas Lacking Good Practice in Health Tech Assessment

FRIDAY, Jan. 25, 2019 (HealthDay News) -- In a report published in the January issue of Value in Health, an ISPOR--The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in three areas of health technology assessment (HTA).

Abstract/Full Text (subscription or payment may be required)

Marketing of Opioids Linked to Increased OD Mortality

WEDNESDAY, Jan. 23, 2019 (HealthDay News) -- Marketing of opioids to physicians is associated with increased mortality from opioid overdoses, according to a study published online Jan. 18 in JAMA Network Open.

Abstract/Full Text
Editorial

Benzodiazepine, Opioid Co-Usage Up in the United States

WEDNESDAY, Jan. 23, 2019 (HealthDay News) -- Concurrent use of benzodiazepine receptor modulators and opioids and of nonselective and selective benzodiazepine receptor modulators increased from 1999-2000 to 2013-2014, according to a study published online Jan. 17 in SLEEP.

Abstract/Full Text (subscription or payment may be required)

Medical Cannabis Decisions Being Made by Users, Not Doctors

TUESDAY, Jan. 22, 2019 (HealthDay News) -- Many patients use medical cannabis without their mainstream health care provider's knowledge, and further, they self-adjust their pharmaceutical use in response to cannabis use, according to a study published online Jan. 8 in the Journal of Psychoactive Drugs.

Abstract/Full Text

FDA Down to 5 Weeks of Funding to Review New Drug Applications

THURSDAY, Jan. 17, 2019 (HealthDay News) -- Due to the federal government shutdown, the U.S. Food and Drug Administration has only about five weeks of funding left to review new drug applications, according to Commissioner Scott Gottlieb, M.D.

CNN News Article

Adoption of Advanced Health IT Capabilities Inconsistent

WEDNESDAY, Jan. 16, 2019 (HealthDay News) -- Adoption of advanced health information technology (HIT) capabilities is inconsistent across health care systems, with electronic health record (EHR) standardization being the strongest predictor of advanced capabilities, according to a study published in the January issue of the American Journal of Managed Care.

Abstract/Full Text

American College of Physicians Releases 7th Edition of Ethics Manual

TUESDAY, Jan. 15, 2019 (HealthDay News) -- Ethical principles are discussed in an updated Ethics Manual, issued by the American College of Physicians (ACP) and published as a supplement to the Jan. 15 issue of the Annals of Internal Medicine.

American College of Physicians Ethics Manual
Editorial (subscription or payment may be required)

One in Five Back Pain Patients Experience Persistent Pain

MONDAY, Jan. 14, 2019 (HealthDay News) -- Eighteen percent of patients with back pain experience a persistent trajectory, according to a study published online Jan. 14 in Arthritis Care & Research.

Abstract/Full Text (subscription or payment may be required)

Persistent Opioid Use High in Head, Neck Cancer Patients

FRIDAY, Jan. 11, 2019 (HealthDay News) -- Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer, according to a study recently published in Otolaryngology-Head and Neck Surgery.

Abstract/Full Text (subscription or payment may be required)

Prices Still Explain High U.S. Health Care Spending

FRIDAY, Jan. 11, 2019 (HealthDay News) -- The difference in health spending between the United States and other countries is still explained by health care prices, according to a study published in the January issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Many Medical Cannabis Users Drive While Under the Influence

THURSDAY, Jan. 10, 2019 (HealthDay News) -- The prevalence of driving under the influence of cannabis (DUIC) is high among medical cannabis users with chronic pain, according to a study published online Jan. 9 in Drug and Alcohol Dependence.

Abstract/Full Text (subscription or payment may be required)

Private Equity Acquisition of Physician Practices Discussed

THURSDAY, Jan. 10, 2019 (HealthDay News) -- The phenomenon of private equity acquisition of physician practices is discussed in an Ideas and Opinions piece published online Jan. 8 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required)

Many Female Health Care Workers Live in Poverty

WEDNESDAY, Jan. 9, 2019 (HealthDay News) -- Many U.S. female health care workers, particularly women of color, live in poverty and lack health insurance, according to a study published online Dec. 20 in the American Journal of Public Health.

Abstract/Full Text (subscription or payment may be required)

Increase in Brand-Name Drug Cost Mainly Due to Existing Drugs

WEDNESDAY, Jan. 9, 2019 (HealthDay News) -- The costs of oral and injectable brand-name drugs increased from 2008 to 2016, with most of the increase due to existing drugs, while new drugs accounted for cost increases in specialty and generic drugs, according to a study published in the January issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Medical Marketing Has Increased in Past 20 Years

TUESDAY, Jan. 8, 2019 (HealthDay News) -- From 1997 through 2016, there was an increase in medical marketing, especially direct-to-consumer (DTC) advertising, according to research published in the Jan. 1/8 issue of the Journal of the American Medical Association.

Abstract/Full Text
Editorial (subscription or payment may be required)
Editorial (subscription or payment may be required)
Editor's Note (subscription or payment may be required)

ACA Coverage Gains Could Erode Without Individual Mandate

TUESDAY, Jan. 8, 2019 (HealthDay News) -- Eliminating the Affordable Care Act's individual mandate penalty is unlikely to destabilize the individual market in California but could roll back coverage gains, according to a study published in the January issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Rx Opioids Up Pneumonia Risk in Patients With, Without HIV

MONDAY, Jan. 7, 2019 (HealthDay News) -- Prescribed opioids are associated with an increased risk for community-acquired pneumonia (CAP) requiring hospitalization among persons with and without HIV, according to a study published online Jan. 7 in JAMA Internal Medicine.

Abstract/Full Text (subscription or payment may be required)

Meta-Analysis: Botulinum A Tops Placebo for Chronic Migraine

MONDAY, Jan. 7, 2019 (HealthDay News) -- For chronic migraine, botulinum type A injections are superior to placebo after three months of therapy, according to a meta-analysis published in the January issue of Plastic and Reconstructive Surgery.

Abstract/Full Text

Gabapentin Improves Sexual Function in Provoked Vulvodynia

MONDAY, Jan. 7, 2019 (HealthDay News) -- For women with provoked vulvodynia, gabapentin improves sexual function compared with placebo, although overall sexual function is still lower than for pain-free controls, according to a study published in the January issue of the American Journal of Obstetrics and Gynecology.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA: Gout Drug Uloric Increases Risk of Death

FDA: Gout Drug Uloric Increases Risk of Death

Medication is associated with increased risk of heart-related death and death from all causes

Since Early 2000s, Overdose Death Rates Are Highest in U.S.

Since Early 2000s, Overdose Death Rates Are Highest ...

U.S. was not an outlier in terms of drug overdose mortality prior to the early 2000s

National Health Spending Set to Increase 5.5 Percent Annually

National Health Spending Set to Increase 5.5 Percent ...

Long-observed demographic and economic factors expected to drive growth in health spending

is free, fast, and customized just for you!




Already a member?

Sign In Now »